Regeneron

LIBTAYO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / LIBTAYO – J9119

Manufacturer:

Regeneron

Name:

LIBTAYO

HCPCS Code Descriptor:

Injection, cemiplimab-rwlc, 1 mg

Category:

J Code

HCPCS:

J9119

NDC(s):

61755-0008-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

LIBTAYO is an Oncology drug manufactured by Regeneron and administered via the Intravenous route of administration. The J Code: J9119 is aligned to the drug LIBTAYO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj., cemiplimab-rwlc, 1 mg

Billing and Coding Guide:

https://www.libtayohcp.com/sfsites/c/resource/Libtayo_Surround_Resources_Assets_Part_2/quick-reference-coding-guide.pdf

Patient Assistance:

https://www.libtayo.com/support

LIBTAYO - J9119